Sabra Health Care REIT (NASDAQ:SBRA) Price Target Increased to $18.00 by Analysts at Scotiabank

Sabra Health Care REIT (NASDAQ:SBRA – Free Report) had its price objective raised by Scotiabank from $17.00 to $18.00 in a report released on Friday morning, Benzinga reports. Scotiabank currently has a sector perform rating on the real estate investment trust’s stock. A number of other analysts have also recently issued reports on SBRA. Truist […]

Leave a Reply

Your email address will not be published.

Previous post TORM (NASDAQ:TRMD) Shares Down 0% – Here’s Why
Next post Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright